Microbial cells can produce a vast spectrum of chemical compounds, including those most desired by the global chemical market, for example, higher alcohols, which are promising alternative fuels and chemical feedstock. In the current research, we investigated the effects of the Ehrlich pathway genetic engineering on higher alcohols production in Yarrowia lipolytica, which directly follows our previous findings concerning elucidation of putative molecular identities involved in this pathway. To this end, we constructed two alternative expression cassettes composed of previously identified genes, putatively involved in the Ehrlich pathway in Y. lipolytica, and cloned them under the control of constitutive pTEF promoter, and by this released them from extensive native regulation. The effects of the pathway engineering were investigated upon provision of different Ehrlich pathway-inducing amino acids (L-Phe, L-Leu, L-Ile and L-Val). In general, amplification of the Ehrlich pathway in many cases led to increased formation of a respective higher alcohol from its precursor. We observed interesting effects of aminotransferase BAT2 deletion on synthesis of 2-phenylethanol and its acetate ester, significant relationship between L-Val and L-Phe catabolic pathways and extensive 'cross-induction' of the derivative compounds synthesis by non-direct precursors.
INTRODUCTION
Growing awareness of the environmental burden imposed by chemical and fuel industry, as well as uncertain supply of the fossil fuels are the major driving forces for development in the green chemistry area. Among the top most desired chemicals on the global market, the authorities and stakeholders name several diols (2,3-butanediol, 1,3-propanediol) , organic acids (succinic acid, lactic acid), lipid/alkene-derived metabolites (ethylene, fatty acids, fatty alcohols) and higher alcohols (butanol, isobutanol) (Sauer, Marx and Mattanovich 2008; Alper and Stephanopoulos 2009; Borodina and Nielsen 2014; Jansen and van Gulik 2014; Dai and Nielsen 2015; Generoso et al. 2015; Nielsen and Keasling 2016) . Higher alcohols are aliphatic, medium-chain compounds of more than three carbon atoms with branched or aromatic side-residues. Due to their useful chemical properties, higher alcohols have found applications in numerous industrial processes, starting from production of alternative fuels, through serving as chemical feedstock, to aromatization of various goods (Nozzi et al. 2014) . Microbial cells can produce a vast spectrum of chemical compounds, including those most desired by the global chemical market. Higher alcohols can be produced in microbial cells de novo by sequestering carbon skeletons from the central carbon metabolism, or in a course of bioconversion from structurally-related precursors. While de novo synthesis seems more reasonable in terms of the culture media costs (no need for the precursors), it is by far less efficient than bioconversion (Schrader et al. 2004) . Bioconversion pathway per se is decoupled from the core carbon metabolism and thus the precursor is not dissipated in the competing pathways.
Higher alcohols, either synthesized de novo or in a course of bioconversion, are inherently coupled with AA metabolism. Catabolism of L-leucine (L-Leu), L-isoleucine (L-Ile), L-valine (L-Val) or L-phenylalanine (L-Phe) leads to the formation of higher alcohols, namely 3-MEB (Isoamyl alcohol; CAS 123-51-3; 3-MBE), 2-MEB (Active Amyl Alcohol; CAS 137-32-6; 2-MBE), 2-MEP (Isobutanol; CAS 78-83-1; 2-MPE) and 2-Phenylethyl Alcohol (2-PE; CAS 60-12-8; 2-PE), respectively. The metabolic pathway of branched chain AAs (L-Val, L-Leu and L-Ileu), aromatic AAs (L-Phe, L-Tyr and L-Trp) and L-Met has been initially described by Ehrlich (Ehrlich 1907) (Fig. 1) . The Ehrlich pathway is executed via three subsequent reactions: deamination, decarboxylation and oxidation, catalyzed by transaminase (like ARO8/9 or BAT1/2 [EC:2.6.-.-.]), 2-oxo acid decarboxylase (like ARO10 or PDC1/3/5 [EC:4.1.1.-]) and dehydrogenase (like ADH1-5 in Saccharomyces cerevisiae; [EC:1.1.1.90]), respectively. It is known that in S. cerevisiae each step can be conducted by several possible enzymes implying that the Ehrlich pathway is highly redundant (Lilly, Lambrechts and Pretorius 2000; Dickinson, Salgado and Hewlins 2003; Vuralhan et al. 2003; Vuralhan et al. 2005; Lilly et al. 2006; Hazelwood et al. 2008) . In terms of the yeast cell physiology, the Ehrlich pathway is used to seize nitrogen from AA. In terms of the chemical industry, it leads to the formation of valuable chemical compounds of significant interest. These chemical compounds derive from the carbon skeletons of the AA that basically remain intact. Synthesis of the higher alcohols may be accompanied by concomitant formation of its ester (3-MEBAc (CAS 123-92-2), 2-MEBAc (CAS 624-41-9), 2-MEPAc (CAS 110-19-0)) or fusel acid (3-MEBacid (CAS 503-74-2) or 2-MEPacid (CAS 79-31-2)), which also find numerous applications in industrial processes. Noteworthy higher alcohols and their esters constitute an important fraction of aroma compounds used in aromatization of various commodities, including foodstuff and cosmetics, where their natural origin is particularly desired (according to European regulation on flavors (EEC No 1334/2008), a chemical compound can be labelled as 'natural' when the 'substance is obtained by appropriate physical, enzymatic or microbial processes from material of vegetable, animal or microbial origin either in the raw state or after processing').
A list of valuable biomolecules synthesized by either native or engineered metabolism of a non-conventional yeast species Yarrowia lipolytica is continuously increasing (Alper and Stephanopoulos 2009; Groenewald et al. 2014; Madzak 2015; Ledesma-Amaro and Nicaud 2016) . Recently, we have shown that Y. lipolytica is an efficient producer of a highly-valued higher alcohol-2-PE in a course of bioconversion from L-Phe (Celińska et al. 2013 ). In the following study, we performed whole-proteome analysis in order to fish out molecular identities involved in the bioconversion of AA to the higher alcohol (Celinska, Olkowicz and Grajek 2015) . Although the general overview of the Ehrlich pathway was known, involvement of the particular molecular identities in this pathway had not been elucidated before in Y. lipolytica. Based on the proteomic data, we observed presence or over-representation of specific proteins which, based on their sequence, function and similarity to S. cerevisiae's 'template' pathway, could be linked to the general pathway of higher alcohols formation. by the transamination by aminotransferase to alpha-keto acid, followed by decarboxylation by decarboxylase to fusel aldehyde, and either oxidation or reduction by dehydrogenase to fusel alcohol or fusel acid, respectively. CAS numbers are provided for those compounds that were analyzed in this study.
all the homologous sequences (ARO10/PDC1/PDC5/PDC6) from S. cerevisiae against Y. lipolytica protein database. The last activity that is directly involved in AAs catabolism via Ehrlich pathway is dehydrogenase. Determining the molecular identities of the dehydrogenase involved in the Ehrlich pathway presents a challenge (Hazelwood et al. 2008) , Dickinson, Salgado and Hewlins (2003) have shown that any of the alcohol dehydrogenases (Adh1-5 and Sfa1) encoded within S. cerevisiae genome can catalyze this final reaction, demonstrating high redundancy of this step. In our previous study, we have observed high overrepresentation of a single dehydrogenase having broad-range substrate specificity-YALI0F24937p. Significant induction of its expression implied its involvement in the catabolism of AAs via the Ehrlich pathway. Consequently, based on comparative whole proteome analysis, we identified candidate genes for genetic manipulations oriented towards enhanced formation of higher alcohols in Y. lipolytica.
In the current research, we investigated the effects of genetic manipulation of the Ehrlich pathway on higher alcohols production in Y. lipolytica. To this end we constructed two alternative expression cassettes composed of previously identified aminotransferases encoded by YALI0E20977g or YALI0F19910g, decarboxylase encoded by YALI0D06930g and YALI0F24937g coding for broad-substrate-specificity dehydrogenase. The genes were cloned under the control of constitutive promoter pTEF and Lip2 terminator; thus, released from the native regulation mechanisms. The three-gene assemblies were transformed in two Y. lipolytica strains (JMY2101 and JMY3150) differing in the genetic background related to the Ehrlich pathway (JMY3150 is deleted for BAT2 aminotransferase, while JMY2101 bears native Ehrlich pathway). It is known that at greater concentrations, higher alcohols exert toxic effect toward microbial cells. Thus, to avoid the toxicity of higher alcohols overproduction, we applied suboptimal conditions of the precursor feeding-in other words, intentionally lowered concentration of the precursory AAs-to enable observation of the modifications' effects. The effects of the pathway amplification were investigated upon provision of different Ehrlich pathway-inducing AAs in comparison to the reference strain.
MATERIALS AND METHODS

Strains and routine culturing conditions
Escherichia coli and Y. lipolytica strains used in this study are listed in Table S1 (Supplementary data). All cultivations required for molecular biology protocols complied with the standards described in Barth and Gaillardin (1996) and Sambrook and Russell (2001) . Briefly, E. coli strains were routinely maintained in LB medium (g/L: 10, bacteriological peptone, 10, NaCl, 5, yeast extract; liquid or solidified with agar, 15 g/L) supplemented with appropriate antibiotic when necessary (ampicillin at 100 μg/L; kanamycin 40 μg/L), at 37
• C, 250 rpm in rotary shaking incubator (Biosan, Riga, Latvia 
Molecular biology protocols
If not stated otherwise, all the molecular biology protocols followed the methodologies described in Sambrook and Russell (2001) . All oligonucleotides and plasmids used in this study are listed in Table S2 (Supplementary data). Escherichia coli and Y. lipolytica transformations were conducted according to the CaCl 2 or LiAc heat-shock methodologies described in Sambrook and Russell (2001) and Barth and Gaillardin (1996) (Hall 1999) and confirmed with control restriction digestions. Elimination of the undesired BsaI recognition sites from the targeted sequences was confirmed through sequencing (GATC Biotech, Ebersberg, Germany; Genomed, Warsaw, Poland) and BsaI restriction digestion. The reactions were conducted according to protocols provided by the manufacturers.
Modular cloning-Golden gate assembly and positive clones' selection
The modular cloning protocol followed the previously set standard (Celinska et al. 2017) . All the plasmids and primers used in this study are listed in Table S2 (Supplementary data).
Briefly, a set of thirteen 4 nt overhangs was developed together with the corresponding destination vector pSB1A3-RFP, (http://parts.igem.org/Collections). Genomic DNA sequence of Y. lipolytica CLIB122 used in this study as GGFs amplification template can be acquired from GRYC database (http://gryc.inra.fr/). All the GGVs (GGF-bearing donor vectors) were constructed using pCR Blunt II TOPO vector's backbone (Thermo Fisher Scientific) and a corresponding GGF amplicon, according to the instruction provided by the manufacturer. Ligation mixture was transformed into one of the E. coli host strains (JM109, TOP10 or DH5α) and correct GGVA organization was confirmed through restriction digestion and electrophoresis. DNA concentration was assessed using NanoDrop spectrophotometer (Thermo Fisher Scientific). The Golden Gate reaction mixture contained precalculated equimolar amounts of each GGF and the destination vector (50 pmoles of ends), 2 μL of T4 DNA ligase buffer (New England Biolabs), 5 U of BsaI, 200 U of T4 and ddH 2 O up to 20 μL. The following thermal cycling profile was applied: [37
the reaction mixtures were used for E. coli JM109 transformation. White colonies were screened for identification of complete GGA through colony PCR covering adjacent elements (e.g. P1˙F and G1 R), followed by plasmid isolation, restriction digestion and multiplex PCR. Complete GGAs were linearized with NotI and transformed into JMY2101 and JMY3150 strains. Clones appearing after 48 h incubation at 30
• C on YNB-selection plates were replica-plated on fresh YNB plates. All the clones were screened for the GGA presence through colony PCR covering adjacent GGFs. All the strains confirmed to bear a complete GGA, were deposited as glycerol stocks at −80 • C.
Batch bioconversion cultures
Batch bioconversion cultures to be analyzed through GC were conducted with at least two subclones of each type: JMY2101 GGA077, JMY3150 GGA077, JMY2101 GGA097 and JMY3150 GGA097; each cultured in triplicate. JMY2900 control strain was cultivated in parallel with each culture run as a non-transformed reference. The cultures were conducted in shake flasks of total volume 50 mL and working volume 5 mL, at 30
• C, 250 rpm. The basal production medium contained in g/L: 50, glycerol, 1 mL, mineral salt solution II (Barth and Gaillardin 1996) used for analysis of biomass accumulation and concentration of Ehrlich pathway-derived compounds. Biomass accumulation was assessed through OD600 measurements using UV/V is Spectrophotometer SPECORD (Analytik Jena, Jena, Germany). Concentration of targeted metabolites retained in the culture medium was determined through gas chromatography analysis (GC; procedure described below). Batch bioconversion cultures to be analyzed through GC-MS were conducted in 300 mL Erlenmeyer flasks in a working volume of 100 mL, in the same medium and under corresponding culturing conditions as described above. Three independent cultivations were conducted for each recombinant strain type (JMY2101 GGA097, JMY3150 GGA097 and JMY2900). Samples were collected after 48 h of culturing and subjected to GC-MS analysis.
Extraction of volatile compounds in the culture media
After thawing, the supernatant samples were vortexed, centrifuged (15 min, 22,639 × g) and passed through 0.45 μm filter (Millex, Merck Millipore). Extraction of the aroma compounds was conducted through mixing the filtrate with equal quantities (GC analysis) or 9:1 ratio (GC-MS analysis) of dichloromethane, vigorous shaking and separation of phases via centrifugation (15 min, 22,639 × g). The organic phase was collected and subjected to either GC or GC-MS analysis. Comparison of the extraction efficiency was assessed by conducting parallel cultivations in different culture volumes (5 mL vs 100 mL) followed by extraction with either 0.5 or 0.1 volume of dichloromethane.
GC analysis
The GC analysis of the organic phase (1 μL) was conducted using Agilent Technologies 7890A System gas chromatograph equipped with a Zebron ZB-WAXplus GC capillary column and FID detector. Mobile phase: hydrogen (30 mL/min), air (300 mL/min), helium (20 mL/min). The oven programme was as follows: 80
• C for 1 min, 80
• C to 120
• C at 20
• C/min, followed by 120
• C to 220
• C at 120
• C/min, and final hold at 220 • C for 3 min. 
GC-MS analysis
GC-MS analysis was conducted at
Statistical analysis
The results were expressed as mean ± standard deviation (±SD) of the replicates, as indicated above. Statistical importance of the differences between compared sets of data was analyzed using one-way analysis of variance (ANOVA) and Tukey's multiple comparison tests (Statistica; Statsoft Inc., Poland). The levels of significance were set at P < 0.01, P < 0.05 and P < 0.1. Graphical presentation of the obtained data was done using Microsoft Excel 2013 software.
RESULTS
Design and construction of recombinant strains
DNA constructions were designed and assembled according to previously described methodology ( Fig. 2A and B) . DNA sequence analysis of the ARO genes revealed that ARO8, BAT2 and ARO10 all bear two internal BsaI sites, which were eliminated through assembly PCR with corresponding 'BsaI del' primers (Table S2 , Supplementary data) and verified through sequencing and in silico translation. Assemblies were first constructed and amplified in E. coli cells. The two constructions are schematically presented in Fig. 2A and B. Each complete DNA construction bears three genes of the Ehrlich pathway (aminotransferase-either BAT2 or ARO8, decarboxylase-ARO10, and dehydrogenaseAdh) under control of pTEF promoter and tLip2 terminator, selection marker URA3 and zeta regions flanking the complete cassette. Subsequently, the correct constructions were transformed into Y. lipolytica JMY2101 and JMY3150 strains. Both strains are uracil auxotrophs, which enables selection of the cassette-bearing clones. Additionally, strain JMY3150 is deleted in BAT2 aminotransferase, involved in the Ehrlich pathway. Clones bearing complete assemblies were selected by colony PCR with primers covering adjacent DNA parts (gene and regulatory element) (Fig. 2C ). Positive clones of each of the four types (JMY2101 bearing either GGA077 and GGA097 assemblies, or JMY3150 bearing GGA077 and GGA097 assemblies) were deposited as glycerol stocks and subjected to further studies.
Bioconversion cultures and analyses
General considerations
Representative clones of the recombinant strains-JMY2101 GGA0077, JMY2101 GGA0097, JMY3150 GGA0077 and JMY3150 GGA0097-were selected and subjected to bioconversion cultures with L-Phe, L-Leu, L-Ile and L-Val as the sole nitrogen sources. The results are presented in Figs 3 and 4, as well as in Supplementary data Figure S1 and Figure S2 .
In general, presuming that overall biomass accumulation reflects feasibility of a given AA assimilation, L-Val was the most easily utilized AA among all the strains (13.82 ± 0.5 OD600), followed by L-Leu (13.64 ± 0.35 OD600 average in JMY2900 and JMY2101), whose assimilation was impaired in bat2 JMY3150 strains (9.64 ± 0.63 OD600; Figs S1.C.G and S2.C.G, Supplementary data). In GGY0077 strains, the weakest growth was observed upon feeding with L-Ile and L-Phe (9.18 ± 0.06 and 8.61 ± 0.39 OD600), while in GGY0097 strains, the lowest OD600 readouts were observed in cultures with L-Phe as the sole nitrogen source (7.1 ± 0.15 OD600; Figs S1.A.E and S2.A, Supplementary data).
GGA0077-bearing strains: ARO8 as the initiating aminotransferase
With respect to the strains transformed with GGA0077 cassette cultured in the bioconversion medium supplemented with L-Phe (Fig. 3A) , more than 50% increase in 2-PE formation was observed when compared to the reference strain (average for the recombinants 0.65 ± 0.064 vs 0.424 ± 0.078 g/L for the reference strain), while the growth was not significantly compromized in the engineered strains (8.6 ± 0.52 vs 10.04 ± 1.04 OD600; Fig.  S1 .A, Supplementary data). The final specific titer of 2-PE was exactly 2-fold higher for the strains bearing recombinant ARO genes under the control of constitutive pTEF promoter (average 0.084 ± 0.001 vs 0.042 g/OD600, for the recombinants and the reference strain, respectively; Fig. S1 .B, Supplementary data). Considering the accompanying metabolites, all the recombinants synthesized ∼50% higher quantities of 2-MEPacid (co-product of L-Val bioconversion) while cultured in L-Phe-supplemented medium, which was demonstrated by both the final concentration and specific titer (average 0.2 ± 0.0014 vs 0.13 ± 0.02 g/L ± SD (1.54-fold increase) and average 0.023 vs 0.012 g/OD600 (1.92-fold increase), for the recombinants and the reference strain, respectively; Fig. 3B and Fig. S1 .B, Supplementary data). The levels of the other analyzed compounds (in g/L; 3-MEBacid, 2-PEAc) were more deviating than actually different (P > 0.1) between the recombinants and the reference strain, however, the final concentration and specific titer of 2-MEB (L-Ile derivative) were uniformly more than 2-fold higher for all the recombinants than for the reference strain (0.011 ± 0.001 vs 0.0038 ± 0.0003 g/L ± SD and 0.0012 vs 0.00038 g/OD600 for the recombinants and the reference strain; Fig. 3B and Fig. S1 .B, Supplementary data). Upon cultivation with L-Phe as the sole nitrogen source, the bat2 genotype in GGY0077s slightly improved 2-PE formation, suggesting a kind of competition for the NH 4 + residues between 'aromatic AA' and 'BCAA' bioconversions, initiated by ARO8 and BAT2 aminotransferases, respectively, which was relieved upon deletion of BAT2 gene in JMY3150. This statement is corroborated by the results obtained with the JMY2101 and JMY3150 strains transformed with GGA0097 cassette (Fig. 4A and Fig. S2 .B, Supplementary data). Additional copy of BAT2 aminotransferase in JMY2101 (altogether 2 copies-one under native regulation and the other under pTEF), ultimately led to slightly lower 2-PE formation in a course of L-Phe bioconversion (g/L ± SD: JMY2101 GGA097: 0.37 ± 0.05/1.37-fold decrease, JMY3150 GGA097: 0.48 ± 0.042/1.06-fold decrease, reference 5 , 9, 13, 17), ARO10-tLip2T2 (lanes: 2, 6, 10, 14, 18), 7, 11, 15, 19) and ura3 (lanes: 4, 8, 12, 16, 20) ; lanes 1-4 (clone 1), 5-8 (clone 2), 9-12 (clone 3), 13-16 (clone 4), 17-20 (negative control-not transformed strain). Positive clones: 1 and 3. M: Gene Ruler Express.
strain: 0.508 ± 0.018), which was also illustrated by specific titers of 2-PE per OD600 (0.053 2-PE g/OD600 giving 1.36-fold decrease for JMY2101 derivatives, 0.066 2-PE g/OD600 giving 1.1-fold decrease for JMY3150 derivatives and 0.072 2-PE g/OD600 for JMY2900; Fig. S2 .B, Supplementary data). Consequently, it can be stated that pTEF-driven expression of ARO10 and Adh did not result in higher bioconversion of L-Phe to 2-PE when BAT2 was concomitantly expressed, either in JMY2101 or JMY3150. On the other hand, amplification of ARO8 and the following genes of the Ehrlich pathway enhanced 2-PE synthesis by more than 50% in the recombinants in general. Further enhancement by more than 60% was observed upon deletion of bat2 . It is commonly now known that AA metabolism is more an extensive net of biochemical reactions than a linear pathway. Hence, we also studied performance of here developed Y. lipolytica recombinants upon provision of the other AA, known to be metabolized through the Ehrlich pathway, namely BCAA (L-Leu, L-Val and L-Ile). Considering recombinants bearing constitutive expression of the Ehrlich pathway in GGA077 variant cultured in BCAA-containing media, expectedly production of 2-PE was rather low, reaching on average 0.01-0.02 g/L (Fig. 3D,  F and H) . Nevertheless, the highest 2-PE concentrations were observed in the case of JMY3150 GGA077 strains (doubled ARO8, ARO10 and Adh, in bat2 ) cultured in L-Val containing media (0.02 ± 0.004 g/L/4.35-fold increase for the JMY3150 derivatives, 0.007 ± 0.001/1.52-fold increase for the JMY2101 derivatives, 0.0046 ± 0.001 g/L for JMY2900; g/L ± SD), again suggesting that bat2 genotype is advantageous for 2-PE formation (Fig. 3H) . Cultivation of the GGA077-bearing strains in L-Ile-containing media showed that the GGA077 modification was the enabling factor for synthesis of 2-PE at detectable levels, as the reference strain did not formed this metabolite at all (Fig. 3F) . Also, an increase in 2-PE and its ester formation was observed for the GGA077-bearing strains cultured in L-Leu-supplemented medium (average for the recombinants 0.0083 ± 0.0014 vs 0.0043 ± 0.0011 g of 2-PE/L ± SD for the reference; 1.93-fold increase; Fig. 3D ).
Interestingly, amplification of the Ehrlich pathway (GGA077) uniformly led to increased formation of a respective higher alcohol, being derivative of the provided BCAA: 3-MEB from L-Leu (0.76 ± 0.038/2.38-fold increase for JMY2101 derivatives, 0.56 ± 0.042/1.75-fold increase for JMY3150 derivatives and 0.32 ± 0.04 for JMY2900; g/L ± SD) (Fig. 3C) , 2-MEP from L-Val (0.077 ± 0.012/2-fold increase for the JMY2101 derivatives, 0.086 ± 0.049/2.26-fold increase for the JMY3150 derivatives and 0.038 ± 0.004 for JMY2900; g/L ± SD) (Fig. 3 .G) and 2-MEB from L-Ile (0.025 ± 0.002/1.6-fold increase for the JMY2101 derivatives, 0.023 ± 0.002/1.5-fold increase for the JMY3150 derivatives and 0.0157 ± 0.002 for JMY2900; g/L ± SD) (Fig. 3E) , which was also reflected by specific titers of the derivative compounds (Fig. S1.D, F and H, Supplementary data). It seems that amplification and constitutive overexpression of the broad range decarboxylase and oxidoreductase and relatively broad range aminotransferase ARO8, improved formation of the higher alcohols. Even more interestingly, the accompanying fusel acid production was concomitantly decreased for the recombinants when compared to the reference strain: 3-MEBacid from L-Leu (0.021 ± 0.0005/1.43-fold decrease for the JMY2101 derivatives, 0.01 ± 0.005/3-fold decrease for the JMY3150 derivatives and 0.03 ± 0.003 for JMY2900; g/L ± SD) and 2-MEPacid from L-Val (0.026 ± 0.0044/3.88-fold decrease for the JMY2101 derivatives, 0.043 ± 0.0041/2.35-fold decrease for the JMY3150 derivatives and 0.101 ± 0.0042 for JMY2900; g/L ± SD), which was also demonstrated by corresponding specific titer values (Fig. S1 .D and H, Supplementary data). Furthermore, we noted that for GGY0077 strains, the titers of 2-MEB (L-Ile derivative) were increased upon supplementation with its 'not direct' precursor BCAA-L-Leu (0.85 ± 0.043/2.36-fold increase for the JMY2101 derivatives, 0.54 ± 0.07/1.5-fold increase for the JMY3150 derivatives and 0.36 ± 0.076 for JMY2900; g/L ± SD) (Fig. 3D) . Both concentrations and specific titers of the two isoforms, 2-MEB and 3-MEB, in a course of L-Leu bioconversion were highly corresponding (0.058/2.5-fold increase and 0.0637/2.5-fold increase in g of 3-MEB and 2-MEB/OD600 for the JMY2101 derivatives, 0.0657/2.6-fold increase and 0.0585/2.3-fold increase in g of 3-MEB and 2-MEB/OD600 for the JMY3150 derivatives, and 0.023 and 0.0259 g of 3-MEB and 2-MEB/OD600 for the reference; Fig.  S1 .D, Supporting Information). Moreover, it seems that ARO8 aminotransferase presence/constitutive expression (GGY0077) does not impose such an unfavorable effect on the BCAA-derived higher alcohols production, as it was observed for the BAT2 and 2-PE/2-PEAc synthesis. It was rather observed that the BCAAderived higher alcohol formation could benefit from higher abundance of the broad-substrate-specificity decarboxylase and the dehydrogenase. Upon overexpression of the Ehrlich pathway with ARO8 aminotransferase in the G1 position (GGY0077), we also observed an interplay between L-Phe and L-Val catabolic pathways. In general, provision of L-Val promoted production of L-Phe derivatives, 2-PE, and its derivative ester (which was more pronounced in bat2 genotype background), when compared to L-Leu and L-Ile, while L-Phe enhanced production of isobutyrate and 2-MEP (derivatives of L-Val) in these recombinant strains.
GGA0097-bearing strains: BAT2 as the initiating aminotransferase
The second expression cassette-GGA0097, differed from the GGA0077 by bearing BAT2 aminotransferase gene in the G1 position. Upon cultivation of GGA097-bearing strains in L-Leusupplemented medium, it was observed that BAT2 gene under native regulation is required for maintaining growth phenotype corresponding to the reference strain, while lack of this gene resulted in impaired growth (1.36-fold decrease in OD600 value; Fig. S2.C, Supporting Information) . Surprisingly, such phenomenon was not observed for the cultures supplemented with L-Ile and L-Val, where the recombinants' growth remained at the native level by pTEF-BAT2 (Fig. S2 .E and G, Supporting Information). The lower growth rate in the JMY3150 derivatives was accompanied by slightly higher level of 3-MEB synthesis when expressed per volume unit (peak concentration at 48 h 0.341 ± 0.0343 vs 0.26 ± 0.034 g/L ± SD for JMY3150 derivatives and the reference strain; 1.31-fold increase), which altogether resulted in importantly increased specific titer (JMY3150 derivatives vs JMY2900: 0.103 ± 0.026 and 0.028 of 3-MEB g/OD600 ± SD at 48 h; 3.67-fold increase; Fig. 4B and Fig. S2 .D, Supporting Information). On the other hand, for the JMY2101 derivatives cultured in L-Leu-based medium the growth characteristic was maintained, still the peak concentration of the derivative higher alcohol at 48 h was only slightly improved, when expressed in g/L (0.32 ± 0.025 vs 0.26 ± 0.034 g/L ± SD for JMY2101 derivatives and the reference strain; 1.23-fold increase), but anyway improved specific titer (0.0377 ± 0.0016 3-MEB g/OD600 ± SD at 48 h; 1.34-fold increase; Fig. 4B and Fig. S2 .D, Supporting Information). With respect to the accompanying metabolites, only 2-PE and 2-PEAc were synthesized at detectable levels by GGY0097 strains in L-Leu-based cultures. While for the JMY2101 derivatives, the increase in 2-PE and 2-PEAc formation was relatively low (2-PE: 0.079 ± 0.014 vs 0.049 g/L ± SD/1.6-fold increase, 2-PEAc: 0.33 ± 0.048 vs 0.154 g/L ± SD/2.14-fold increase, for the recombinants vs the reference), in bat2 strains 2-PE and 2-PEAc formation was strongly enhanced (more than 4-fold in both cases) up to 0.21 ± 0.023 and 0.745 ± 0.047 g/L ± SD at 72 h of culturing, even upon supplementation with L-Leu and not L-Phe (Fig.  4C) , which was also reflected by significantly enhanced specific titers: 0.074 ± 0.011/6.7-fold increase in 2-PEAc g/OD600 ± SD at 72 h and 0.021 ± 0.004/6-fold increase in 2-PE g/OD600 ± SD at 72 h for JMY3150 GGA0097 (Fig. S2 .D, Supporting Information).
As mentioned above, constitutive expression of the Ehrlich pathway in GGA0097 variant, reconstituted growth impairment observed for bat2 strains cultured in L-Ile and L-Val-containing media. Upon cultivation with L-Ile, the GGA0097 modification minimally increased production of 2-MEB only in the JMY2101 strains (at 24 h: 0.35 ± 0.02 vs 0.27 ± 0.015 g/L ± SD/1.3-fold increase for JMY2101 derivatives vs the reference), while in the JMY3150 derivatives, its production remained at the reference level (Fig. 4D) . In all strains, 2-MEB was converted to its corresponding acetate ester, starting from approximately 48 h. In GGY0097 strains cultures with L-Ile, we observed slightly increased titers of 3-MEBacid (derivative of L-Leu; 0.0132 ± 0.002/1.4-fold increase for the JMY2101 derivatives, 0.011 ± 0.0008/1.16-fold increase for the JMY3150 derivatives and 0.0095 ± 0.0017 g/L ± SD for JMY2900; Fig. 4E ), while production of 2-PE was observed only in bat2 strains. Surprisingly, none of GGY0097s differed significantly from JMY2900 in production of major L-Val products (2-MEP and its ester) (Fig. 4F) . However, in JMY3150 GGA0097 strains' cultures supplemented with L-Val, slightly higher levels of 2-PE and 2-PEAc were observed at specific time-points, when compared to the JMY2900 reference strain (2-PEAc at 24 h: 1.163 ± 0.003/1.43-fold increase for the JMY2101 derivatives, 0.96 ± 0.08/1.18-fold increase for the JMY3150 derivatives and 0.813 ± 0.04 g/L ± SD for JMY2900; 2-PE at 48 h: 0.42 ± 0.05/2-fold increase for the JMY2101 derivatives, 0.22 ± 0.03/1.05-fold for the JMY3150 derivatives, 0.21 ± 0.05 g/L ± SD for JMY2900; Fig. 4G ). At the following time points, the 2-PEAc concentration dropped from over 1 g/L to zero in the JMY3150 cultures, which was not the case for the remaining strains. Moreover, the production of 2-PE was continued only in the JMY3150 derivatives which again indicates important effect of bat2 on 2-PE formation and also important relationship between L-Val and L-Phe pathways.
DISCUSSION
The current study directly follows our previous findings concerning elucidation of putative molecular identities involved in bioconversion of precursory AA to higher alcohols via Ehrlich bioconversion pathway in Y. lipolytica (Celinska, Olkowicz and Grajek 2015) . Consequently, here we modified previously identified elements of the Ehrlich pathway in Y. lipolytica cells by either their overexpression under strong, constitutive promoter or knock-out, and investigated effects of such manipulations on the yeast cell metabolism. Previous attempts of the Ehrlich pathway manipulation in S. cerevisiae mainly relied on single gene deletion or overexpression which led to corresponding reduction or increase in the derivative bioconversion products (2-MEB, 3-MEB, 3-MEBacid and 2-MEPacid) (Vuralhan et al. 2005; Lilly et al. 2006; Styger et al. 2013) . More complex strategy relied on deletion of Ald3 gene (catalyzes phenylacetaldehyde oxidation, competing with 2-PE production) in a strain overexpressing ARO9 and ARO10 and ARO80 transcription factor, which altogether resulted in increased formation of the derivative higher alcohol (Kim et al. 2014a) . Another interesting approach aimed at intensification of de novo isobutanol production (2-MEP) by re-location of part of Ehrlich pathway to mitochondria (decarboxylation and reduction) (Brat et al. 2012) . Natively, the upstream de novo 2-MEP pathway is located in mitochondria, while the downstream steps, executed by α-ketoacid decarboxylase and alcohol dehydrogenase of Ehrlich pathway, are localized in cytoplasm. In order to secure availability of intermediates without the need for transportation between the compartments, the whole pathway was targeted to mitochondria, which significantly improved titer, yield and productivity of the higher alcohol (Brat et al. 2012) .
Due to possible differences in the experimental setups, direct comparison of own and literature data concerning any bioprocess is not always fully justified. Nevertheless, such comparisons allow to locate own data in relation to the state-of-art. The aim of the present study was manipulation with putative genes of Ehrlich pathway in Y. lipolytica and examination of its effect on higher alcohols production. Thus, the bioconversion cultures were conducted under suboptimal conditions in terms of amount of the precursory AA. The rationale behind such approach was to enable observation of differences caused by the introduced modifications prior to reaching toxic concentration of the higher alcohols. Considering overall titers of higher alcohols that were obtained in the cultures, the highest levels of 2-PE were obtained in L-Phe supplemented cultures of JMY3150 GGAA0077 and JMY2101 GGA0077 (>0.7 g/L), followed by approximately 0.5 g/L produced by JMY3150 GGA0097. The highest levels of 2-PE's acetate ester (2-PEAc), which is highly valued aroma compound, were reached surprisingly in L-Val or L-Leu supplemented cultures (and not L-Phe) of JMY3150 GGA0097 strain (>1.0 and >0.74 g/L). Isobutanol (2-MEP) was accumulated at the highest concentration (0.347 g/L) in L-Val supplemented cultures of JMY3150 GGA0097, while 2-MEB and its isoform (3-MEB), in L-Leu, supplemented cultures of JMY2101 GGA0077 (0.85 and 0.75 g/L, respectively). As reported previously 2-MEP could be accumulated up to 0.16 g/L by wild type S. cerevisiae, and up to 0.45 g/L by mutant strain, out of 2 g/L of L-Leu supplemented into the culture medium (Abe and Horikoshi 2005) . Its isomer, n-butanol, could be accumulated from provided glycine via artificial pathway up to 0.092 g/L in engineered S. cerevisiae (Branduardi et al. 2013) . Industrial S. cerevisiae JP1 strain cultured in L-Leu supplemented (at 9.8 g/L) bioreactor cultivations, produced up to 1.1 g/L of 3-MEB, together with 0.08 g/L of 2-MEP and 0.05 g/L of 2-PE (Espinosa Vidal et al. 2015) . Up to date, the highest levels of 2-MEP that have been synthesized de novo (up to 0.63 g/L) were reported for recombinant S. cerevisiae strain having part of Ehrlich pathway re-located to mitochondria (Brat et al. 2012) .
In here designed expression cassettes, aminotransferaseencoding genes (ARO8 or BAT2) were located in the first transcription unit. Depending on the assembly variant, either YALI0E20977g or YALI0F19910g gene, encoding ARO8 or BAT2 aminotransferase homologs from S. cerevisiae, respectively, was cloned in this position. ARO8 aminotransferase is mainly associated with deamination of L-Phe; however, it has been experimentally shown that it possess relatively broad-substratespecificity, as it can act on L-Phe as the amino group donor with α-ketoisocaproate and α-keto-γ (methylthio)butyrate, providing the connection node between L-Phe and L-Leu and L-Met metabolic pathways (Urrestarazu et al. 1998; Iraqui et al. 1999) . On the other hand, BAT2 is known to be involved in both the first step of BCAA decomposition, as well as the last step of their synthesis (BAT1 isozyme in mitochondria), while no earlier reports on its activity with aroma AA have been published to date (according to www.uniprot.org; UniProtKB-P47176). In the current study we have observed that while overexpression of the Ehrlich pathway in GGA0077 variant had significant modulatory effect on several higher alcohols formation upon cultivation in L-Phe but also BCAA-supplemented media (higher production of a respective higher alcohol and increase/decrease in the fusel acid formation), the opposite setup (GGA0097 and L-Phe supplemented medium) had the adverse effect on targeted higher alcohol production. These results well correspond with the above-mentioned findings on substrate specificity of the two aminotransferases-ARO8 and BAT2-in S. cerevisiae. It seems unlikely that YALI0E20977p (ARO8) could directly act on BCAA; however, our data suggest it is highly probable that it can interact with intermediates of BCAA catabolism, as it was shown for S. cerevisiae ARO8. Interestingly, our current results indicate that over-representation of BAT2 activity decreases production of aroma AA-derived metabolites (2-PE and 2-PEAc), while its reduction (by generation of bat2 genotype) leads to their higher formation. This observation uniformly applied to all the analyzed experimental variants (different GGAs, BAT2 + or bat2 genotype, different AA fed to the culture media). Altogether, it can be concluded that aroma AA and BCAA pathways initiated by ARO8 and BAT2 aminotransferases, respectively, compete/act synergistically in terms of sequestering amino groups from AA. This phenomenon can be seen as competition, since it decreases titers of targeted higher alcohol and its ester, but considering the cell physiology, it dissipates the carbon skeletons and amino groups into different pathways, making the process more efficient. Such dissipation of amino groups into different products has been earlier observed in many studies on higher alcohols production (e.g. Espinosa Vidal et al. 2015; Celińska et al. 2018) . Moreover, it has been shown in S. cerevisiae that generation of Aro8 genotype underlies the transcriptional upregulation of ARO10, which leads to increased de novo production of 2-PE during growth on glucose and causes substantial changes in the absolute and relative intracellular concentrations of AAs (Romagnoli et al. 2015) . Our data suggest existence of similar phenomenon operating between BAT2 aminotransferase and ARO10 decarboxylase (as seen in bat2 ); however, further research is needed to support such conclusion.
As demonstrated previously, overexpression or deletion of BAT2 gene in S. cerevisiae triggered respectively enhanced or decreased formation of derivative higher alcohols and acids from their corresponding precursory BCAA (Lilly et al. 2006) . In the present study, overexpression of BAT2 under control of strong pTEF promoter enhanced formation of 3-MEB from L-Leu in terms of specific titer, as well as 3-MEBacid from L-Ile by both JMY2101-and JMY3150 derivatives. Interestingly, for unbiased induction of 2-MEB formation from L-Ile, an additional BAT2 copy under native regulation was necessary, since in JMY3150 derivatives bearing GGA0097 cassette the metabolite production remained at the native level, while in JMY2101 derivatives a significant increase in 2-MEB formation from L-Ile was observed. Importantly, the concentrations of the keto-acid (isovalerate) and the downstream higher alcohol (2-MEB) were highly correlated in the GGA0097-bearing strains, cultured under L-Ile provision. L-Ile promoted production of 2-PE solely in JMY3150-derived strains, which was not observed for the reference and JMY2101-derived strains. Such 'cross-induction' of the derivative compounds synthesis by a non-direct precursors has been shown earlier for S. cerevisiae (Lilly et al. 2006; Espinosa Vidal et al. 2015) . In a study by (Lilly et al. 2006) , it was observed L-Val promotes formation of 2-MEP and 2-MEPacid (straightforward bioconversion products), L-Leu and L-Ile are both converted to 3-MEB and 3-MEBacid, and also that L-Leu indirectly contributes to 2-PE formation. It was indicated that supplementation of the growth media with individual BCAAs results in increased levels of the corresponding higher alcohols and acids but also the other, non-direct bioconversion products (Lilly et al. 2006) . Our current results are in agreement with those presented by Lilly et al. (2006) , as we have observed that L-Val improved production of 2-PE and its derivative ester in JMY3150˙GGA077/GGA097 strains; L-Leu enhances production of 2-MEB (L-Ile metabolism), especially in the case of JMY2101 GGA077 strains; L-Phe stimulates production of isobutyrate (derivative of L-Val) in JMY2101-/JMY3150 GGA077 strains; ARO8 overexpression in presence of native BAT2 (JMY2101) strongly increases titers of 2-MEB (L-Ile derivative) in a course of L-Leu bioconversion. As observed earlier in S. cerevisiae (Vuralhan et al. 2005) , induction of an Ehrlich pathway for catabolism of a given AA leads to the formation of significant amounts of fusel alcohols and acids from the other precursor, which implies that conversion of BCAA, aroma AA and sulfur-containing AAs to the corresponding fusel alcohols and acids, via an Ehrlich pathway, involves common broadsubstrate-specificity enzyme activities (Vuralhan et al. 2003; Vuralhan et al. 2005; Hazelwood et al. 2008) . Such construction of the pathway enables flexible interchanging between the individual sub-pathways. In our previous study (Celinska, Olkowicz and Grajek 2015) , we have observed high over-representation of 2-oxoisovalerate dehydrogenase E1 (YALI0D08690g and YALI0F05038g; primarily associated with L-Val), isovaleryl-CoA dehydrogenase (YALI0E12573g; primarily associated with L-Leu) and 3-oxoacid CoA transferase (YALI0F26587g; primarily associated with L-Leu) as well as 3-hydroxyisobutyryl-CoA hydrolase (YALI0D06215g; primarily associated with L-Val) upon provision of L-Phe as the sole nitrogen source. This suggests that apart from tight connection between BCAAs catabolic sub-pathways, such tight linkage functions also for the other, more structurally distinct substrates metabolized via the Ehrlich pathway in Y. lipolytica as well.
Although the crucial role in the Ehrlich bioconversion pathway is attributed to the initializing aminotransferase (Romagnoli et al. 2015) , the important contribution of the following keto acid decarboxylase and dehydrogenase cannot be neglected (Romagnoli et al. 2012) . Indeed, previous studies with Kluyveromyces marxianus have shown that upon overexpression of ARO10 and the following alcohol dehydrogenase (ADH2) genes from S. cerevisiae significantly improved de novo synthesis of 2-PE (Kim et al. 2014b) . In the present study we focused on a single gene, encoding decarboxylase activity-YALI0D06930p (a homolog of ARO10 from S. cerevisiae), which was the only protein, putatively catalyzing the keto acid decarboxylation reaction, identified in the previous proteomic study (Celinska, Olkowicz and Grajek 2015) . As earlier proved in S. cerevisiae (Vuralhan et al. 2005) , ARO10 is responsible for a broad-substrate-specificity decarboxylase activity involved in production of fusel alcohols and acids, showing superior kinetic properties when compared with the other isozymes-PDCs (Romagnoli et al. 2012) . In S. cerevisiae, several different decarboxylases can operate in the Ehrlich pathway. For L-Leu catabolism, KID1 decarboxylase acts with keto isocaproate, for L-Val, any of the three isozymes of pyruvate decarboxylase encoded by PDC1, PDC5, and PDC6 can decarboxylate α-ketoisovalerate, while the broadest range of isozymes can conduct this reaction during L-Ile degradation, including PDC1, PDC5, PDC6, YDL080c or YDR380w (Dickinson, Salgado and Hewlins 2003; Hazelwood et al. 2008) . Nevertheless, only ARO10-encoding gene's expression was strongly up-regulated in the presence of L-Phe, L-Leu and L-Met (the transcript level was at least 15-fold higher than in cultures grown with ammonium sulfate), which coincided with induction of the Ehrlich pathway. Such strong up-regulation was not observed for PDC5, PDC6, PDC1 and THI3. Since only ARO10 was differentially and highly transcribed upon cultivation in different nitrogen sources, it was concluded that it operates as the most potent and flexible decarboxylase in the Ehrlich pathway (Vuralhan et al. 2005) . Moreover, overexpression of ARO10 in S. cerevisiae strain, in which the five chromosomal decarboxylase genes had been deleted, was sufficient to restore a broad-substrate-specificity decarboxylase activity. More research is needed to elucidate molecular bases of this step of Ehrlich pathway in Y. lipolytica. It might be useful to identify specific decarboxylases in order to more precisely manipulate with the Ehrlich pathway, to ultimately obtain narrowed spectrum of metabolites. On the other hand, it might be challenging to reach more 'focused' Ehrlich pathway, as it is known that the individual steps are highly redundant, the enzymatic activities have broad-substrate specificity, and the intermediates are shared between different branches, as for example α-oxoisovalerate (L-Val metabolism) that is known, shared intermediate of BCAAs turnover.
It was previously shown that 2-MEP, 3-MEB and 2-MEB can all be re-metabolized by S. cerevisiae cells in a specific culturing condition, namely stationary phase, after exhaustion of glucose, ethanol or acetate carbon sources in long-term batch cultures, using minimal medium with glucose as the initial carbon source and L-Leu as the sole nitrogen source (Vuralhan et al. 2005) . As neither growth nor ester formation were observed concomitantly with depletion of the higher alcohols, the authors concluded that this re-metabolization might play a role in the maintenance of the redox balance through reduction of NAD+, while oxidizing the higher alcohols into their corresponding aldehydes in the opposite direction to the final reductive step of the Ehrlich pathway, and could potentially be used as carbon sources after further oxidation to the corresponding acid and assimilation by β-oxidation. Our cultures were conducted until the major carbon source was exhausted from the media (72 h), and we have not observed such a phenomenon. Probably, prolonged cultivations could answer whether such a phenomenon occurs also in Y. lipolytica cells. However, we observed that 2-MEB (GGA097 LIle) and 2-MEP (GGA097 L-Val) are converted to its acetate ester, production of which is correlated with decrease in the alcohol concentration. Such correlation was not observed for 2-MEB (GGA077, cultured with L-Ile), 2-MEP (GGA077, cultures with LVal) and also 2-MEP (both GGAs, L-Leu), where their corresponding acetate esters were synthesized, but not in parallel to decrease in the alcohol concentration.
Our current data also demonstrate that, similarly to S. cerevisiae, in Y. lipolytica the AA precursors can be partly transformed into the corresponding fusel acid. It was earlier suggested that the ratio between the final concentrations of synthesized acid or alcohol depends on the redox state of the cell (Dickinson and Dawes 1992) . Interestingly, we observed that overexpression of the Ehrlich pathway in GGA077 variant and cultivation of the resulting strains in BCAA (L-Leu, L-Ile and L-Val)-containing media led to significantly decreased synthesis of the fusel acid, when compared to the reference strain. In the view of former findings in S. cerevisiae it might indicate favorable change in the redox state of the cell followed by the modification or, overexpression of dehydrogenase YALI0F24937p with high preference for reduction reaction and low reversibility.
CONCLUSIONS AND PERSPECTIVES
In summary, the present study reports effects of manipulation with Ehrlich pathway on production of valuable higher alcohols in Y. lipolytica. The here adopted modification strategy contributed to improved production of targeted higher alcohol in many cases, but also enabled observation of several interesting phenomena. First of all, we observed that bat2 genotype promotes formation of aromatic higher alcohol and its derivative acetate ester, suggesting either competition between the aroma AA-and BCAA-initiated pathways in sequestering ammonium residues, or existence of regulation mechanism between aminotransferase and decarboxylase genes, as it was observed for S. cerevisiae. Correspondingly, doubling BAT2 gene (JMY2101 GGA0097) decreases formation of 2-PE from LPhe. Moreover, we observed an interplay between L-Val and L-Phe pathways, especially in GGA0077-bearing strains (crossinduction of derivative higher alcohols). Interestingly, upon overexpression of GGA0077 cassette genes, we observed enhanced formation higher alcohols deriving from L-Leu and L-Val, and concomitantly decreases fusel acid production.
This study deals with primary engineering of aroma AA and BCAA three-step bioconversion pathway, ultimately leading to many valuable higher alcohols. Obviously, production of higher alcohols from pure AA is not economically feasible. Still, as demonstrated by several studies (discussed above) application of metabolic engineering strategies may successfully redirect necessary carbon skeletons from central metabolism to be further converted by the Ehrlich pathway activities. On the other hand, to add to sustainability of higher alcohols production from AA, a protein-rich raw materials, e.g. whey, which is not completely absorbed by the market, could serve as the cost-effective feedstock. Such solution would definitely constitute an added value of the higher alcohols production process, but also would complement the biorefinery concept.
